Latest Information Update: 09 Jan 2004
At a glance
- Originator Aventis
- Developer Virogen
- Class Antivirals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Hepatitis B; HIV infections
Most Recent Events
- 09 Jan 2004 No development reported - Preclinical for HIV infections treatment in United Kingdom (unspecified route)
- 09 Jan 2004 No development reported - Preclinical for Hepatitis B in United Kingdom (unspecified route)
- 02 May 2001 New profile